Weight loss and diabetes management drug linked to increased residual gastric content before anesthesia
University of Texas Health Science Center at HoustonSafety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study published today in JAMA Surgery.